Globe Life Inc. GL
Set alert
158.97 USD -0.82 -0.51%
As of Nov 3, 12:43 PM ET
158.23 Day range 159.92
130.37 52-week range 186.02
- YTD
- +13.66%
- 1 year
- +21.69%
- Open
- 159.60
- Prev close
- 159.79
- Mkt cap
- 12.22B
- Vol
- 155.50K
- Avg vol
- 513.02K
- EPS
- 14.94
- P/E
- 10.64
- Div yield
- 0.82%
More statistics
- Low
- 158.23
- High
- 159.92
- Forward P/E
- 9.76
- Beta
- 0.46
- Short ratio
- 0.07
- Inst. own
- 89.83%
- Dividend
- 1.32
- Ex-div date
- Oct 4, 2026
- Earnings
- Feb 3, 2027
- 50-d avg
- 168.29
- 200-d avg
- 159.70
- 1y target
- 185.18
3M chart
Events in this range
- Oct 5, 2026Dividend: 0.33
- Oct 12, 2026Rating: Wells Fargo · Overweight → Overweight
- Oct 15, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 21, 2026Earnings: 4.84; estimate 4.9; surprise -1.22%
- Oct 23, 2026Rating: TD Cowen · Buy → Buy
- Oct 23, 2026Rating: Evercore ISI Group · In-Line → In-Line
- Oct 23, 2026Downgrade: Piper Sandler · Overweight → Neutral
- Oct 26, 2026Rating: Wells Fargo · Overweight → Overweight
Signals (16)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 13, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 7, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
Financial health
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 3
- P/B 2
Valuation
P/E 9.8×
FY 2016 5y median 11.9× FY 2025
P/S 1.9×
FY 2016 5y median 1.9× FY 2025
P/B 1.9×
FY 2016 5y median 1.9× FY 2025
P/FCF 9.0×
FY 2016 5y median 8.1× FY 2025
EV/EBITDA 8.7×
FY 2016 5y median 8.7× FY 2025
EV/Sales 2.3×
FY 2016 5y median 2.3× FY 2025
FCF Yield 11.1%
FY 2016 5y median 12.4% FY 2025
Profitability
Gross Margin 33.4%
FY 2016 5y median 32.4% FY 2025
Operating Margin 24.4%
FY 2016 5y median 23.0% FY 2025
Net Margin 19.4%
FY 2016 5y median 18.5% FY 2025
ROE 19.4%
FY 2016 5y median 20.2% FY 2025
ROIC 4.0%
FY 2016 5y median 3.7% FY 2025
ROA 3.8%
FY 2016 5y median 3.5% FY 2025
Growth (YoY)
Revenue 3.8%
FY 2016 FY 2025
Operating Income 10.3%
FY 2016 FY 2025
EPS (diluted) 17.8%
FY 2016 FY 2025
Free Cash Flow -5.8%
FY 2016 FY 2025
Financial Health
Current Ratio 9.7×
FY 2016 5y median 9.7× FY 2025
Quick Ratio 9.7×
FY 2016 5y median 9.7× FY 2025
Debt / Equity 0.4×
FY 2016 5y median 0.5× FY 2025
Net Debt / EBITDA 1.6×
FY 2016 5y median 1.6× FY 2025
Interest Coverage 10.4×
FY 2016 5y median 11.7× FY 2025
Dividends
Dividend Yield 0.8%
FY 2016 5y median 0.8% FY 2025
Payout Ratio 7.4%
FY 2016 5y median 8.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
